Not sure which peptide fits your goal? Take the 60 second match

Peptide guide

TB-500.
Data, not hype.

A thymosin beta-4 fragment with real laboratory science behind it and almost no human trial record.

TB-500 vial with freeze-dried peptide powder
Reviewed for medical accuracy · Sources at the end of this page

The short answer

TB-500 is a synthetic peptide built from the active region of thymosin beta-4, a natural protein that binds actin and helps cells migrate into damaged tissue. The parent protein has a legitimate research record, including human studies of eye surface healing. The injectable product sold to athletes and gym users under the name TB-500 has never been tested in an adequate human trial, is not approved by the FDA, and is banned in sport at all times.

ClassThymosin beta-4 fragment
FDA statusNot approved, banned in sport
FormSubcutaneous or intramuscular injection
Evidence levelAnimal data, no trials of TB-500 itself

What the research shows

  • The parent protein — thymosin beta-4 is one of the most abundant actin-binding proteins in cells and is released at sites of injury. Its role in cell movement and wound repair is established laboratory biology, not a fringe idea.
  • Human studies exist, but not of the injection — thymosin beta-4 has been carried into clinical research mainly as an eye drop for corneal surface disease and in early wound healing work. Those results say nothing about milligram doses injected under the skin for a torn hamstring.
  • Animal repair models — rodent work reports improved healing in heart, skin and muscle injury models, with faster recruitment of repair cells into damaged tissue. Animal healing data has a long history of not translating.
  • Racing and veterinary use — much of the practical use history comes from horses, which is where the compound first drew doping attention.
  • What is missing — no published randomized human trial of TB-500 for tendon, muscle or joint injury. Every before and after story circulating online is uncontrolled.

Dosing in practice

A physician decides whether anything should be dosed at all. The ranges below are those reported in practice and in product literature, given for orientation rather than as guidance.

Protocols usually describe a loading phase of roughly 2 to 2.5 milligrams twice weekly for four to six weeks, followed by a maintenance dose in the same size given every second week or monthly. Note the unit — TB-500 is dosed in milligrams while BPC-157 is dosed in micrograms, a thousandfold difference that people mix up when reconstituting powder and reading insulin syringe units.

Check your syringe units

Side effects and risks

  • No controlled human safety data — there is no study population whose adverse events were tracked, so any side effect list is anecdotal.
  • Commonly described by users — injection site reactions, a brief head rush or fatigue after dosing, and occasional flu-like feeling in the first days.
  • Cell growth concern — a compound that promotes cell migration and new vessel formation is a poor choice for anyone with a cancer history, and that judgment belongs to a physician.
  • Product quality — unregulated vials have been found with incorrect strength and with contamination, and an injected impurity is far more dangerous than a swallowed one.
  • Sport — TB-500 is prohibited at all times as a growth factor under the World Anti-Doping Agency list, and it has produced sanctions in several sports.

Legal and FDA status

TB-500 has no FDA approval for any human condition and no accepted medical use in the United States. It is not a recognized dietary ingredient, so products presenting it as a supplement are outside the rules. Vials are typically sold with a research use only label, which shifts legal responsibility to the buyer and guarantees nothing about purity. Athletes under testing should treat it as an automatic violation.

Among peptides discussed on this site, bremelanotide and tesamorelin are FDA-approved drugs. BPC-157, TB-500, CJC-1295, ipamorelin and MOTS-c are not FDA approved for any use.

How people get it legally

There is no lawful prescription route to TB-500 in the United States, and that is the most useful fact on this page. What a physician can do is examine the injury you are trying to fix, order imaging if it is warranted, and offer options with actual evidence behind them, from rehabilitation protocols to injections that are approved and studied. If a peptide still makes sense in your case, the doctor can point to one that a licensed pharmacy may lawfully prepare.

Find what fits your goal

Questions people ask

Which is better, BPC-157 or TB 500?
Evidence cannot answer that, because neither has a completed human efficacy trial. They are usually described as working differently, BPC-157 on new blood vessel growth and gut tissue, TB-500 on cell migration through actin binding. Preference between them is opinion, not data.
Can I take TB 500 every day?
Reported protocols use twice weekly dosing rather than daily, because the compound is thought to persist and spread through tissue rather than act locally for a few hours. There is no human study defining a safe frequency, so daily use is an experiment on yourself.
Does TB 500 raise testosterone?
No known mechanism connects it to testosterone production, and no human data supports the claim. It appears in marketing copy because testosterone sells, not because it was measured.
What are the side effects of TB-500?
Without a trial there is no verified list. Users describe injection site irritation, fatigue and lightheadedness soon after dosing. The serious concerns are unknown vial contents and the theoretical risk of feeding growth in an undiagnosed tumor.
How long can you stay on BPC-157 and TB-500?
Typical reported courses run four to eight weeks with a break afterward, and nobody can tell you what continuous use does over years because it has never been studied. Long-term self-dosing of an unapproved compound is the part of this that carries real risk.

Sources: PubMed — thymosin beta-4 research · WADA Prohibited List · USADA on unapproved peptides · FDA — bulk substances safety list